SUSANNA LILJENSTOLPE: Open Payments
NPI 1992224513 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$569 in 21 payments from 11 companies in 2025. Trend: 2023 $169 · 2024 $230 · 2025 $569
Food & beverage: $569
| Company | Payments | Amount |
|---|---|---|
| Endologix LLC | 3 | $189 |
| Novartis Pharmaceuticals Corporation | 4 | $100 |
| PFIZER INC. | 3 | $62 |
| Koya Medical, Inc. | 3 | $46 |
| CARDIVA MEDICAL, INC. | 1 | $35 |
| Amgen Inc. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Organogenesis Inc. | 1 | $23 |
| Baxter Healthcare | 1 | $15 |
Products named: AFX2 Bifurcated Endograft System, LEQVIO, Alto Abdominal Stent Graft System, VYNDAQEL, KOYA MEDICAL, CARDIVA VASCADE MVP VVCS 6-12F, REPATHA, INSPIRE.
Industry payments across AZ — which companies pay providers there.
